CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2006-08-30): IBD patients need better immunization

Clinical

IBD patients need better immunization

Last Updated: 2006-08-30 15:30:25 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Patients with inflammatory bowel disease (IBD) are frequently not immunized against vaccine-preventable diseases, despite their compromised immune status that puts them at high risk, according to researchers, who call for better efforts to vaccinate these patients.

Dr. Gil Y. Melmed of Cedars-Sinai Medical Center, Los Angeles, and colleagues had 169 patients from their IBD specialty clinic complete surveys with questions about immunization status, exposure to preventable diseases such as influenza, pneumococcus, varicella and viral hepatitis, and their general medical condition. One hundred forty-six (86%) reported taking immunosuppressive medications currently or in the recent past.

Only 45% recalled receiving a tetanus vaccination in the past 10 years, 28% received regular influenza vaccination and 9% reported recent pneumococcal vaccination, according to the report in the August issue of the American Journal of Gastroenterology.

Lack of awareness of the need for immunization, reported by 49%, was the number one reason for not receiving vaccines. Another 18% said they were concerned over possible side effects.

Although 44% were at risk of exposure to hepatitis B virus (HBV), only 28% had received the vaccine. Among those who reported a history of HBV vaccination, only 33% had measurable antibodies to hepatitis B surface antigen.

Dr. Melmed's group points out that patients who are going to receive immunosuppressive treatment, such as those about to have an organ transplant, are checked for immunization status and vaccinated accordingly before treatment begins.

The researchers conclude that there is a need for "a paradigm shift in the initial management of patients with IBD and other chronic illnesses who have a reasonable likelihood of future immunosuppression."

Am J Gastroenterol 2006;101:1834-1840.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.